Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells

American Journal of Pathology

Volumn 168, Issue 6, 2006, Pages 2014-2026

  Su, Gui ^a   Meyer, Kristy ^a   Nandini, Chilkunda D ^a   Qiao, Dianhua ^a   Salamat, Shahriar ^a   Friedl, Andreas ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLYCOSAMINOGLYCAN; GLYPICAN; GLYPICAN 1; MONOCLONAL ANTIBODY; PROTEOHEPARAN SULFATE; RNA; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOGENESIS; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 33744729372     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050800     Document Type: Article

References (49)

1. Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H, Hatanaka M: Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 1990, 87:5710-5714
2. Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE: Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 1990, 50:7393-7398
3. Saxena A, Ali IU: Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines. Oncogene 1992, 7:243-247
4. Gross JL, Morrison RS, Eidsvoog K, Herblin WF, Kornblith PL, Dexter DL: Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth. J Neurosci Res 1990, 27:689-696
5. Yamaguchi F, Saya H, Bruner JM, Morrison RS: Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 1994, 91:484-488
6. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M: Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 2000, 6:743-750
7. Raman R, Venkataraman G, Ernst S, Sasisekharan V, Sasisekharan R: Structural specificity of heparin binding in the fibroblast growth factor family of proteins. Proc Natl Acad Sci USA 2003, 100:2357-2362
8. Turnbull J, Powell A, Guimond S: Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol 2001, 11:75-82
9. Raman R, Sasisekharan V, Sasisekharan R: Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol 2005, 12:267-277
10. Kleeff J, Ishiwata T, Kumbasar A, Friess H, Buchler MW, Lander AD, Korc M: The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 1998, 102:1662-1673
11. Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U: Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2002, 2:521-528
12. Filmus J: Glypicans in growth control and cancer. Glycobiology 2001, 11:19R-23R
13. Adatia R, Albini A, Carlone S, Giunciuglio D, Benelli R, Santi L, Noonan DM: Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA. Ann Oncol 1997, 8:1257-1261
14. Steck PA, Moser RP, Bruner JM, Liang L, Freidman AN, Hwang TL, Yung WK: Altered expression and distribution of heparan sulfate proteoglycans in human gliomas. Cancer Res 1989, 49:2096-2103
15. Allen BL, Filla MS, Rapraeger AC: Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J Cell Biol 2001, 155:845-858
16. Qiao D, Meyer K, Mundhenke C, Drew SA, Friedl A: Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells: specific role for glypican-1 in glioma angiogenesis. J Biol Chem 2003, 278:16045-16053
17. Mundhenke C, Meyer K, Drew S, Friedl A: Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol 2002, 160:185-194
18. Karlsson M, Bjornsson S: Quantitation of proteoglycans in biological fluids using Alcian blue. Methods Mol Biol 2001, 171:159-173
19. Lee PH, Trowbridge JM, Taylor KR, Morhenn VB, Galo RL: Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment. J Biol Chem 2004, 279:48640-48646
20. Chandrasekhar S, Esterman MA, Hoffman HA: Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal Biochem 1987, 161:103-108
21. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P: Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 1992, 12:240-247
22. Kinoshita A, Sugahara K: Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides. Anal Biochem 1999, 269:367-378
23. David G, Van der SB, Marynen P, Cassiman JJ, Van Den BH: Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol 1992, 118:961-969
24. Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999, 17:1474-1481
25. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M: Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996, 271:15292-15297
26. Glimelius B, Norling B, Westermark B, Wasteson A: Composition and distribution of glycosaminoglycans in cultures of human normal and malignant glial cells. Biochem J 1978, 172:443-456
27. Richard C, Liuzzo JP, Moscatelli D: Fibroblast growth factor-2 can mediate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells. J Biol Chem 1995, 270:24188-24196
28. Kasza A, Kowanetz M, Poslednik K, Witek B, Kordula T, Koj A: Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells. Cytokine 2001, 16:187-190
29. Wu Y, Zhang Y, Cao L, Chen L, Lee V, Zheng PS, Kiani C, Adams ME, Ang LC, Paiwand F, Yang BB: Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. J Biol Chem 2001, 276:14178-14186
30. Glimelius G, Norling B, Westermark B, Wasteson A: Turnover of cell surface associated glycosaminoglycans in cultures of human normal and malignant glial cells. Exp Cell Res 1978, 117:179-189
31. Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell TL: Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 2000, 407:1029-1034
32. Turnbull J, Drummond K, Huang Z, Kinnunen T, Ford-Perriss M, Murphy M, Guimond S: Heparan sulphate sulphotransferase expression in mice and Caenorhabditis elegans. Biochem Soc Trans 2003, 31:343-348
33. David G, Bai XM, Van der SB, Cassiman JJ, Van Den BH: Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992, 119:961-975
34. Fukumoto M, Takahashi JA, Murai N, Ueba T, Kono K, Nakatsu S: Induction of apoptosis in glioma cells: an approach to control tumor growth by blocking basic fibroblast growth factor autocrine loop. Anticancer Res 2000, 20:4059-4065
35. Tang P, Steck PA, Yung WK: The autocrine loop of TGF-alpha/EGFR and brain tumors. J Neurooncol 1997, 35:303-314
36. Kapoor GS, O'Rourke DM: Mitogenic signaling cascades in glial tumors. Neurosurgery 2003, 52:1425-1434
37. Steinfeld R, Van Den BH, David G: Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol 1996, 133:405-416
38. Song HH, Shi W, Filmus J: OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. J Biol Chem 1997, 272:7574-7577
39. Lin X, Perrimon N: Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling. Nature 1999, 400:281-284
40. Song HH, Filmus J: The role of glypicans in mammalian development. Biochim Biophys Acta 2002, 1573:241-246
41. Matsuda K, Maruyama H, Quo F, Kleeff J, Itakura J, Matsumoto Y, Lander AD, Korc M: Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 2001, 61:5562-5569
42. Chen RL, Lander AD: Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. J Biol Chem 2001, 276:7507-7517
43. Ishihara M, Kariya Y, Kikuchi H, Minamisawa T, Yoshida K: Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. J Biochem (Tokyo) 1997, 121:345-349
44. Berry D, Shriver Z, Natke B, Kwan CP, Venkataraman G, Sasisekharan R: Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1. Biochem J 2003, 373:241-249
45. Pye DA, Vives RR, Turnbull JE, Hyde P, Gallagher JT: Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem 1998, 273:22936-22942
46. Lundin L, Larsson H, Kreuger J, Kanda S, Lindahl U, Salmivirta M, Claesson-Welsh L: Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis. J Biol Chem 2000, 275:24653-24660
47. Lai J, Chien J, Staub J, Avula R, Greene EL, Matthews TA, Smith DI, Kaufmann SH, Roberts LR, Shridhar V: Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J Biol Chem 2003, 278:23107-23117
48. Dai Y, Yang Y, MacLeod V, Yue X, Rapraeger AC, Shriver Z, Venkataraman G, Sasisekharan R, Sanderson RD: HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J Biol Chem 2005, 280:40066-40073
49. Pan C, Nelson MS, Reyes M, Koodie L, Brazil JJ, Stephenson EJ, Zhao RC, Peters C, Selleck SB, Stringer SE, Gupta P: Functional abnormalities of heparan sulfate in mucopolysaccharidosis-1 are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells. Blood 2005, 106:1956-1964